264 related articles for article (PubMed ID: 18694299)
1. Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer.
Catarino R; Ferreira MM; Rodrigues H; Coelho A; Nogal A; Sousa A; Medeiros R
DNA Cell Biol; 2008 Aug; 27(8):415-21. PubMed ID: 18694299
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients.
Huang ZH; Li LH; Hua D
Cancer Lett; 2006 Nov; 243(1):64-70. PubMed ID: 16412565
[TBL] [Abstract][Full Text] [Related]
3. Circulating Plasma Tumor DNA.
Parsons HA; Beaver JA; Park BH
Adv Exp Med Biol; 2016; 882():259-76. PubMed ID: 26987539
[TBL] [Abstract][Full Text] [Related]
4. Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer.
Sunami E; Vu AT; Nguyen SL; Giuliano AE; Hoon DS
Ann N Y Acad Sci; 2008 Aug; 1137():171-4. PubMed ID: 18837943
[TBL] [Abstract][Full Text] [Related]
5. Quantification of free circulating DNA as a diagnostic marker in lung cancer.
Sozzi G; Conte D; Leon M; Ciricione R; Roz L; Ratcliffe C; Roz E; Cirenei N; Bellomi M; Pelosi G; Pierotti MA; Pastorino U
J Clin Oncol; 2003 Nov; 21(21):3902-8. PubMed ID: 14507943
[TBL] [Abstract][Full Text] [Related]
6. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
7. Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer.
Kamel AM; Teama S; Fawzy A; El Deftar M
Tumour Biol; 2016 Jun; 37(6):7565-72. PubMed ID: 26684805
[TBL] [Abstract][Full Text] [Related]
8. Measurement of circulating cell-free DNA levels by a simple fluorescent test in patients with breast cancer.
Agassi R; Czeiger D; Shaked G; Avriel A; Sheynin J; Lavrenkov K; Ariad S; Douvdevani A
Am J Clin Pathol; 2015 Jan; 143(1):18-24. PubMed ID: 25511138
[TBL] [Abstract][Full Text] [Related]
9. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H; Müller V; Stahmann N; Pantel K
Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
[TBL] [Abstract][Full Text] [Related]
10. Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer.
Kumari S; Tewari S; Husain N; Agarwal A; Pandey A; Singhal A; Lohani M
Pathol Oncol Res; 2017 Jan; 23(1):91-97. PubMed ID: 27475647
[TBL] [Abstract][Full Text] [Related]
11. Use of cell free DNA in breast oncology.
Canzoniero JV; Park BH
Biochim Biophys Acta; 2016 Apr; 1865(2):266-74. PubMed ID: 27012505
[TBL] [Abstract][Full Text] [Related]
12. Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients.
Agostini M; Enzo MV; Bedin C; Belardinelli V; Goldin E; Del Bianco P; Maschietto E; D'Angelo E; Izzi L; Saccani A; Zavagno G; Nitti D
Cancer Biomark; 2012; 11(2-3):89-98. PubMed ID: 23011155
[TBL] [Abstract][Full Text] [Related]
13. Real-time polymerase chain reaction quantification of free DNA in serum of patients with polyps and colorectal cancers.
Danese E; Montagnana M; Minicozzi AM; De Matteis G; Scudo G; Salvagno GL; Cordiano C; Lippi G; Guidi GC
Clin Chem Lab Med; 2010 Nov; 48(11):1665-8. PubMed ID: 20704532
[TBL] [Abstract][Full Text] [Related]
14. Levels of circulating cell-free serum DNA in benign and malignant breast lesions.
Zanetti-Dällenbach RA; Schmid S; Wight E; Holzgreve W; Ladewing A; Hahn S; Zhong XY
Int J Biol Markers; 2007; 22(2):95-9. PubMed ID: 17549664
[TBL] [Abstract][Full Text] [Related]
15. Free circulating DNA as possible tumour marker in colorectal cancer.
Boni L; Cassinotti E; Canziani M; Dionigi G; Rovera F; Dionigi R
Surg Oncol; 2007 Dec; 16 Suppl 1():S29-31. PubMed ID: 18024018
[TBL] [Abstract][Full Text] [Related]
16. [Quantification of plasma DNA as a tumor marker in patients with pancreatic cancer].
Lee KH; Yoon WJ; Lee JK; Ryu JK; Kim YT; Yoon YB
Korean J Gastroenterol; 2005 Sep; 46(3):226-32. PubMed ID: 16179843
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer.
Sefrioui D; Sarafan-Vasseur N; Beaussire L; Baretti M; Gangloff A; Blanchard F; Clatot F; Sabourin JC; Sesboüé R; Frebourg T; Michel P; Di Fiore F
Dig Liver Dis; 2015 Oct; 47(10):884-90. PubMed ID: 26160500
[TBL] [Abstract][Full Text] [Related]
18. [Plasma DNA measurement as a biomarker of cancer].
Czeiger D; Agassi R; Sebbag G; Zlotnik A; Douvdevani A; Shaked G
Harefuah; 2014 Oct; 153(10):569-72, 625. PubMed ID: 25518072
[TBL] [Abstract][Full Text] [Related]
19. Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients.
Catarino R; Coelho A; Araújo A; Gomes M; Nogueira A; Lopes C; Medeiros R
PLoS One; 2012; 7(6):e38559. PubMed ID: 22701665
[TBL] [Abstract][Full Text] [Related]
20. Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy.
Gautschi O; Bigosch C; Huegli B; Jermann M; Marx A; Chassé E; Ratschiller D; Weder W; Joerger M; Betticher DC; Stahel RA; Ziegler A
J Clin Oncol; 2004 Oct; 22(20):4157-64. PubMed ID: 15483026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
